Kobayashi Pharmaceutical Co (TSE:4967) Cyclically Adjusted PB Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4967 Kobayashi Pharmaceutical Co Ltd TSE:4967
76 GF Score
Price 円5,473.00
GF Value 円4,686.81
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Kobayashi Pharmaceutical Co Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kobayashi Pharmaceutical Co  (TSE:4967) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Kobayashi Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms


Kobayashi Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Kobayashi Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.77 4.32 3.01 2.55 2.11

Kobayashi Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.15 2.12 2.11 0.00 0.00

TSE:4967 vs PG, CL, KVUE: Cyclically Adjusted PB Ratio Comparison

For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kobayashi Pharmaceutical Co Cyclically Adjusted PB Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kobayashi Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


TSE:4967
76GF Score
Kobayashi Pharmaceutical Co Ltd TSE:4967
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kobayashi Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Kobayashi Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Kobayashi Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2820.686/113.6000*113.6000
=2,820.686

Current CPI (Jun. 2026) = 113.6000.

Kobayashi Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 1,716.490 98.000 1,989.727
201612 1,818.931 98.400 2,099.904
201703 1,895.993 98.100 2,195.564
201706 1,831.576 98.500 2,112.356
201709 1,868.827 98.800 2,148.773
201712 1,948.269 99.400 2,226.593
201803 1,951.144 99.200 2,234.375
201806 2,020.989 99.200 2,314.358
201809 2,091.010 99.900 2,377.765
201812 2,102.450 99.700 2,395.570
201903 2,103.985 99.700 2,397.319
201906 2,085.271 99.800 2,373.615
201909 2,138.595 100.100 2,427.017
201912 2,208.935 100.500 2,496.866
202003 2,180.456 100.300 2,469.589
202006 2,241.201 99.900 2,548.553
202009 2,301.242 99.900 2,616.828
202012 2,335.913 99.300 2,672.303
202103 2,379.758 99.900 2,706.111
202106 2,437.893 99.500 2,783.363
202109 2,486.419 100.100 2,821.750
202112 2,516.196 100.100 2,855.543
202203 2,489.208 101.100 2,796.974
202206 2,580.383 101.800 2,879.484
202209 2,652.549 103.100 2,922.692
202212 2,603.455 104.100 2,841.042
202303 2,611.496 104.400 2,841.628
202306 2,739.977 105.200 2,958.758
202309 2,819.068 106.200 3,015.500
202312 2,755.162 106.800 2,930.584
202403 2,757.193 107.200 2,921.802
202406 2,821.305 108.200 2,962.110
202409 2,753.494 108.900 2,872.332
202412 2,871.521 110.700 2,946.746
202503 2,785.267 111.100 2,847.942
202506 2,801.235 111.700 2,848.884
202509 2,852.285 112.000 2,893.032
202512 2,838.335 113.000 2,853.406
202603 2,810.301 112.700 2,832.744
202606 2,820.686 113.600 2,820.686

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Kobayashi Pharmaceutical Co (TSE:4967) Overvalued in 2026?

Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be overvalued. The current stock price of 円5,473.00 is trading 16.8% above its estimated GF Value™ of 円4,686.81. GuruFocus considers Kobayashi Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for TSE:4967:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: 円4,686.81 vs. price of 円5,473.00 (16.8% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the TSE:4967 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kobayashi Pharmaceutical Co Business Description

Address 4-4-10 Doshomachi, KDX Kobayashi Doshomachi Building, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
76GF Score

Get the complete analysis for TSE:4967

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円5,473.00
Price
円4,686.81
GF Value